In addition to phosphatase and tensin homolog (PTEN) and phosphatidylinositol 3-kinase (PIK3CA) mutations, which are the most common in Type I endometrial cancer, other mutations have been identified in KRAS and cadherin associated protein (β-catenin) genes [16]. The gene discussed is PTEN; the disease is endometrial cancer.